Mind + Muscle

technical minds + legal muscle


dig deep

The Future of Biosimilars: Mapping Critical Uncertainties and the Impact of Future Events

  • 07.16.14
  • FirstWord Pharma

Paul A. Calvo, Ph.D. contributed his knowledge of intellectual property law to a recent FirstView Advisory Report. The report discusses current and imminent issues facing the biosimilars market, and how they might shape the evolution of the industry. Dr. Calvo contributed to a discussion concerning the legal tactics now commonly employed by both originator and biosimilar companies.

FirstView aims to provide data, expert opinion, and insight on issues and changes in the pharmaceutical industry. They boast leading market research capabilities and expertise accompanied by more than one million industry contributors.

Related People

Related Industries

Sort By Media Type

Sort By Media Type
  • AlertAlert
  • BriefsBriefs
  • Comments to USPTOComments to USPTO
  • Design Patent Case DigestDesign Patent Case Digest
  • MultimediaMultimedia
  • News & ArticlesNews & Articles
  • Press ReleasePress Release
  • VideoVideo
  • WebinarWebinar

Unsolicited e-mails and information sent to Sterne, Kessler, Goldstein & Fox P.L.L.C. will not be considered confidential or privileged, may be disclosed to others, may not receive a response, and do not create an attorney-client relationship with Sterne Kessler.  If you are not already a client of Sterne Kessler, do not include any confidential information in this message.